share_log

完美醫療:中期報告 2024/2025

PERFECT MEDICAL: INTERIM REPORT 2024/2025

HKEX ·  Dec 9 18:50

Summary by Futu AI

完美醫療健康管理有限公司公佈截至2024年9月30日止六個月中期業績。期內收益同比減少13.6%至620.3百萬港元,主要由於香港及中國內地需求減少,加上外遊增加影響本地零售消費。醫療美容業務仍為主要收入來源,貢獻總銷售的73.3%。每名醫療美容服務客戶的平均消費同比下跌36.6%至17,243港元,反映客戶轉向更具性價比的選擇。集團實施嚴格成本控制措施以管理利潤率。僱員福利開支同比下跌8.6%至217.6百萬港元,市場推廣開支減少9.6%至77.2百萬港元,租金租賃相關開支減少8.4%至76.2百萬港元。EBITDA同比減少19.9%至193.9百萬港元,EBITDA利潤率為31.3%。本公...展開全部
完美醫療健康管理有限公司公佈截至2024年9月30日止六個月中期業績。期內收益同比減少13.6%至620.3百萬港元,主要由於香港及中國內地需求減少,加上外遊增加影響本地零售消費。醫療美容業務仍為主要收入來源,貢獻總銷售的73.3%。每名醫療美容服務客戶的平均消費同比下跌36.6%至17,243港元,反映客戶轉向更具性價比的選擇。集團實施嚴格成本控制措施以管理利潤率。僱員福利開支同比下跌8.6%至217.6百萬港元,市場推廣開支減少9.6%至77.2百萬港元,租金租賃相關開支減少8.4%至76.2百萬港元。EBITDA同比減少19.9%至193.9百萬港元,EBITDA利潤率為31.3%。本公司權益持有人應佔利潤為140.8百萬港元,同比減少15.4%,純利率為22.7%。董事會建議派發中期股息每股11.2港仙及特別股息每股0.1港仙。展望未來,集團將繼續優化服務組合,擴大市場份額,並致力於提升營運效率及維持審慎的成本管理,以確保穩定的利潤率。集團亦計劃在主要中心設立VIP休息室,吸引富裕客戶,並將整合人工智能驅動客戶服務工具至營運中,以提升客戶體驗。
Perfect Medical Health Management Limited announced its interim results for the six months ended September 30, 2024. During this period, revenue decreased by 13.6% year-on-year to HKD 620.3 million, primarily due to reduced demand in hong kong and mainland china, coupled with increased outbound travel affecting local retail consumer spending. The medical beauty business remains the main source of revenue, contributing 73.3% of total sales. The average consumer spending per medical beauty service customer dropped by 36.6% year-on-year to HKD 17,243, reflecting a shift towards more cost-effective options. The group implemented strict cost control measures to manage profit margins. Employee benefit expenses decreased by 8.6% year-on-year to HKD 217.6 million, marketing expenses reduced by 9.6% to HKD 77.2 million, and rental-related expenses decreased...Show More
Perfect Medical Health Management Limited announced its interim results for the six months ended September 30, 2024. During this period, revenue decreased by 13.6% year-on-year to HKD 620.3 million, primarily due to reduced demand in hong kong and mainland china, coupled with increased outbound travel affecting local retail consumer spending. The medical beauty business remains the main source of revenue, contributing 73.3% of total sales. The average consumer spending per medical beauty service customer dropped by 36.6% year-on-year to HKD 17,243, reflecting a shift towards more cost-effective options. The group implemented strict cost control measures to manage profit margins. Employee benefit expenses decreased by 8.6% year-on-year to HKD 217.6 million, marketing expenses reduced by 9.6% to HKD 77.2 million, and rental-related expenses decreased by 8.4% to HKD 76.2 million. EBITDA declined by 19.9% year-on-year to HKD 193.9 million, with an EBITDA margin of 31.3%. The profit attributable to equity holders of the company was HKD 140.8 million, a 15.4% year-on-year decline, with a net profit margin of 22.7%. The board of directors proposed an interim dividend of HKD 0.112 per share and a special dividend of HKD 0.01 per share. Looking ahead, the group will continue to optimize its service portfolio, expand market share, and focus on improving operational efficiency while maintaining cautious cost management to ensure stable profit margins. The group also plans to establish VIP lounges in major centers to attract affluent clients and will integrate ai-driven customer service tools into its operations to enhance the customer experience.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.